Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 36,545	$ 7,259
Adjustments to reconcile net income to cash flows (used in) provided by operating activities:
Depreciation and amortization	32,689	32,499
Stock-based compensation expense	4,327	4,695
Other non-cash items	1,107	877
Changes in assets and liabilities, net of acquisitions of businesses:
Accounts receivable, net	(131,059)	(123,072)
Inventories, net	32,892	131,708
Prepaid expenses and other assets	(2,392)	5,577
Accounts payable, trade	12,038	25,822
Accrued expenses and other liabilities	6,199	(10,689)
Net cash flows (used in) provided by operating activities	(7,654)	74,676
Cash flows from investing activities:
Capital expenditures	(8,608)	(17,159)
Acquisitions of businesses	0	(6,250)
Other investing activities	173	1,960
Net cash flows used in investing activities	(8,435)	(21,449)
Cash flows from financing activities:
Vesting of stock-based awards, net of shares tendered for payment of taxes	(9,040)	(8,888)
Proceeds from revolving credit facility	86,248	165,300
Repayments under revolving credit facility	(76,927)	(201,385)
Repayments under term loan and other borrowings	(5)	(5,276)
Payment of dividends	(26,721)	(26,563)
Other financing activities	(2)	(12)
Net cash flows used in financing activities	(26,447)	(76,824)
Effect of exchange rate changes on cash and cash equivalents	(996)	(437)
Net decrease in cash and cash equivalents	(43,532)	(24,034)
Cash and cash equivalents at beginning of period	66,157	47,499	$ 47,499
Cash and cash equivalents at end of period	22,625	23,465	$ 66,157
Supplemental disclosure of cash flow information:
Interest	7,391	9,052
Income taxes, net of refunds	359	390
Purchase of property and equipment in accrued expenses	$ 407	$ 2,304